ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007

Comprehensive Centers Could Lose That Designation By Not Producing

May 30, 1975

NCI Dispute GAO Charge That Cancer Control Contracts Were Mishandled

August 15, 1980

In Brief: A Third Of Smokers Quit For Smokeout-Gallup; 77 Percent Pass Oncology Nursing Examination

November 23, 1990

NCI Division To Promote Funds To Promote Collaboration.

February 18, 2000

Clearinghouse Asks Short Term Test Use To Help In Chemical Selection

September 17, 1977